SGLT2i treatment at the beginning of real time exposure in a HFrEF population

Back

HFA Premium Access

SGLT2i treatment at the beginning of real time exposure in a HFrEF population

Session: ePosters in chronic heart failure - pharmacotherapy 6

Topic: Pharmacotherapy

Speaker: Associate Professor V. Vintila (Bucharest, RO)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Associate Professor Vlad Damian Vintila

University of Medicine and Pharmacy Carol Davila, Bucharest (Romania)

0 follower

4 more presentations in this session

What factors are associated with myocardial recovery following admission for acute heart failure? Study in patients with de novo diagnosis and reduced left ventricular ejection fraction

Speaker: Mr V. Donoso (Valencia, ES)

Nation-wide use of guideline-directed medical therapies in heart failure across the ejection fraction range: The HECMOS study

Speaker: Doctor I. Leontsinis (Athens, GR)

The daily challenges to patients posed by diuretic therapy; what they are and what do patients do?

Speaker: Doctor G. Bruno (Dublin, IE)

CA125 outperforms NT-proBNP in the prediction of maximum aerobic capacity in heart failure with preserved ejection fraction and cardiorenal syndrome

Speaker: Mr G. Nunez Marin (Valencia, ES)

Access the full session

ePosters in chronic heart failure - pharmacotherapy 6

Speakers: Associate Professor V. Vintila, Mr V. Donoso, Doctor I. Leontsinis, Doctor G. Bruno, Mr G. Nunez Marin

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources